叶酸受体阳性循环肿瘤细胞检测在喉鳞状细胞癌诊断中的应用价值

doi:10.6040/j.issn.1673-3770.0.2022.433

摘要/Abstract

摘要： 目的探讨42例喉鳞状细胞癌(LSCC)患者血清中叶酸受体阳性循环肿瘤细胞(FR⁺-CTCs)的水平及其在LSCC诊断中的应用价值。方法检测42例LSCC患者和22例喉良性病变患者外周血中FR⁺-CTCs水平,分析FR⁺-CTCs与LSCC临床病理因素的关系。用受试者工作曲线(receiver operating characteristic curve, ROC)分析FR⁺-CTCs检测在LSCC诊断中的工作效能。结果 LSCC组FR⁺-CTCs水平高于喉良性病变组,差异具有统计学意义(t=7.269,P<0.001)。血清FR⁺-CTCs水平与肿瘤临床分期、T分期、分化等级有关(P<0.05),与性别、年龄、部位、吸烟史、淋巴结转移无关(P>0.05)。ROC曲线显示:以9.0 FU/3 mL为血清FR⁺-CTCs的最佳cut-off值诊断LSCC,曲线下面积(area under curve, AUC)为0.857,其敏感度为76.2%,特异度为95.5%。结论 LSCC患者外周血FR⁺-CTCs水平较喉良性病变患者升高,且增高程度与临床分期及分化等级相关,FR⁺-CTCs检测有望应用于LSCC的临床诊断。

关键词: 喉癌, 叶酸受体, 循环肿瘤细胞, 血清, 生物标志物

Abstract: Objective To determine serum levels of folate receptor-positive circulating tumor cells(FR⁺-CTCs)in patients with laryngeal squamous cell carcinoma(LSCC)and investigate its utility in the diagnosis of LSCC. Methods Forty-two patients with LSCC and 22 with benign laryngeal lesions admitted to the authors’ hospital were enrolled in this study. The significance of peripheral blood levels of FR⁺-CTCs, combined with clinical characteristics, in the diagnosis of LSCC was analyzed. Results FR⁺-CTC levels in patients with LSCC were higher than those in the benign group(t=7.269, P<0.001). Additionally, FR⁺-CTC level was associated with clinical stage, T stage, and differentiation grade(P<0.05), but not with sex, age, location, smoking, or lymph node metastasis(P>0.05). The area under the receiver operating characteristic curve was 0.857; sensitivity was 76.2% and specificity was 95.5% for the detection of LSCC with 9.0 FU/3 mL as the cut-off value. Conclusion Peripheral blood levels of FR⁺-CTCs in patients with LSCC were increased and was associated with clinical stage and differentiation grade. The determination of FR⁺-CTC levels is anticipated to be applied in the clinical diagnosis of LSCC.

Key words: Laryngeal cancer, Folate receptor, Circulating tumor cell, Serum, Biomarkers

中图分类号:

R739.6

张竹萍,叶琪,郭蓓,林凌. 叶酸受体阳性循环肿瘤细胞检测在喉鳞状细胞癌诊断中的应用价值[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 50-53.

ZHANG Zhuping, YE Qi, GUO Bei, LIN Ling. Diagnostic utility of folate receptor-positive circulating tumor cells in patients with laryngeal squamous cell carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 50-53.

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: a cancer journal for clinicians, 2018, 68(6): 394-424. doi: 10.3410/f.734004835.793587632
[2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA A Cancer J Clin, 2016, 66(1): 7-30. doi:10.3322/caac.21332
[3] Tinhofer I, Staudte S. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook[J]. Expert Rev Mol Diagn, 2018, 18(10): 897-906. doi:10.1080/14737159.2018.1522251
[4] He W, Kularatne SA, Kalli KR, et al. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands[J]. Int J Cancer, 2008, 123(8): 1968-1973. doi:10.1002/ijc.23717
[5] 汪莹, 申复进, 郑红云, 等. 叶酸受体阳性循环肿瘤细胞在卵巢癌辅助诊断和疗效监测中的应用价值[J]. 实用临床医药杂志, 2022, 26(13): 79-83, 92. doi:10.7619/jcmp.20220206 WANG Ying, SHEN Fujin, ZHENG Hongyun, et al. Application value of folate receptor-positive circulating tumor cells in auxiliary diagnosis and therapeutic effect monitoring of ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 79-83, 92. doi:10.7619/jcmp.20220206
[6] Yan S, Guo WY, Liu YL, et al. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study[J]. Int J Clin Oncol, 2022, 27(3): 538-544. doi:10.1007/s10147-021-02097-2
[7] Li Z, Xu K, Xu LK, et al. Predictive value of folate receptor-positive circulating tumor cells for the preoperative diagnosis of lymph node metastasis in patients with lung adenocarcinoma[J]. Small Methods, 2021, 5(6): e2100152. doi:10.1002/smtd.202100152
[8] Yu Y, Chen ZL, Dong JS, et al. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer[J]. Transl Oncol, 2013, 6(6): 697-702. doi:10.1593/tlo.13535
[9] Kong LY, Birkeland AC. Liquid biopsies in head and neck cancer: current state and future challenges[J]. Cancers(Basel), 2021, 13(8): 1874. doi:10.3390/cancers13081874
[10] 刘坤, 张欣欣. 循环肿瘤细胞在头颈部鳞癌中的富集及检测[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 18-24. doi:10.6040/j.issn.1673-3770.1.2019.039 LIU Kun, ZHANG Xinxin. Progress in clinical research on circulating tumor cells in squamous cell carcinoma of the head and neck[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 18-24. doi:10.6040/j.issn.1673-3770.1.2019.039
[11] 李倩, 郑琪, 马婕群, 等. 叶酸受体阳性循环肿瘤细胞检测的临床研究进展[J]. 标记免疫分析与临床, 2020, 27(2): 356-360. doi:10.11748/bjmy.issn.1006-1703.2020.02.036 LI Qian, ZHENG Qi, MA Jiequn, et al. The progress of clinical research on folate receptor-positive circulating tumor cells analysis[J]. Labeled Immunoassays and Clinical Medicine, 2020, 27(2): 356-360. doi:10.11748/bjmy.issn.1006-1703.2020.02.036
[12] Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions[J]. J Clin Invest, 2009, 119(6): 1429-1437. doi:10.1172/JCI36183
[13] Li Z, Xu K, Xu LK, et al. Predictive value of folate receptor-positive circulating tumor cells for the preoperative diagnosis of lymph node metastasis in patients with lung adenocarcinoma[J]. Small Methods, 2021, 5(6): e2100152. doi:10.1002/smtd.202100152
[14] Wu Q, Zheng HY, Gu J, et al. Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer[J]. J Clin Lab Anal, 2022, 36(1): e24180. doi:10.1002/jcla.24180
[15] Lian SY, Yang LJ, Feng Q, et al. Folate-receptor positive circulating tumor cell is a potential diagnostic marker of prostate cancer[J]. Front Oncol, 2021, 11: 708214. doi:10.3389/fonc.2021.708214
[16] Yan S, Guo WY, Liu YL, et al. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study[J]. Int J Clin Oncol, 2022, 27(3): 538-544. doi:10.1007/s10147-021-02097-2
[17] Wu XL, Tu Q, Faure G, et al. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis[J]. Sci Rep, 2016, 6: 20210. doi:10.1038/srep20210
[18] Rizzo MI, Ralli M, Nicolazzo C, et al. Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: comparative pre- and post-operative analysis and association with prognosis[J]. Oncol Lett, 2020, 19(6): 4183-4188. doi:10.3892/ol.2020.11528
[19] 陈燕. 叶酸受体在鼻咽癌、喉癌中的表达及临床意义[D]. 重庆: 重庆医科大学, 2007

相关文章 15

[1]	张西,邓启成,张震,程瑶,王靖淞,赵锐,刘海. 营养支持对喉癌术后咽瘘影响的Meta分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 51-59.
[2]	徐翀,王晓亭,易红良. 单细胞测序分析喉癌及其微环境代谢相关靶基因[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 33-38.
[3]	黄恒丰,马鲲鹏,杨迪,张丽君,张盛林. miR-181b-5P和EPB41L3蛋白在喉癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 41-46.
[4]	李利杰,田秀芬. CO₂激光联合低温等离子治疗早期声门型喉癌40例[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 79-85.
[5]	王媚李志海. 喉癌干细胞:克服多药耐药性的潜在治疗靶点[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 120-128.
[6]	程雷,许秋艳,陈浩. 变态反应检测与诊断的临床应用及意义[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 1-6.
[7]	王晓亭,陈正侬,易红良. 利用RNA-seq探讨谷氨酰胺剥夺对喉癌细胞转录组的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 26-31.
[8]	冯成敏,敬一丹,刘海,王冰. 咽喉部鳞状细胞癌细胞系[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 113-124.
[9]	李艳杰, 贾建,杨萍,万保罗. 肿瘤异常蛋白在喉癌临床诊断中的价值研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 70-74.
[10]	陈国平,傅敏仪,叶飞,徐建慧. 早期声门型喉癌钬激光与CO₂激光手术对比研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 8-11.
[11]	吴允刚,张辉,孙聚兴,刘涛,王彩华,杨欣欣,马林祥,李笑颖,庞太忠,李晓瑜. 环甲膜联合喉室入路切除T1B声门型喉癌临床疗效分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 30-34.
[12]	石玉琦,佘翠平,张庆丰,刘得龙,焦梦思. 早期声门型喉癌低温等离子射频术后喉部感染诊治经验与教训[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 129-134.
[13]	周恩,肖禹,肖旭平. 等离子射频消融技术在早期声门型喉癌治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 9-15.
[14]	李健忠,周永锐,李慧英,李妙编,孙一涤,邱前辉. 彩超引导低温等离子消融术在甲状腺良性结节的临床应用研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 34-38.
[15]	肖旭平,周恩,肖禹. 等离子点状激发射频消融技术治疗早期声门型喉癌(T_is-T_1b)31例[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 60-66.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed